Stryker Corp. Hits Day High with Strong 3.8% Intraday Surge

Stryker Corp., a prominent player in the Pharmaceuticals & Biotechnology sector, has seen a notable uptick in its stock performance today, gaining 3.8% as of March 16, 2026. The stock reached an intraday high of USD 350.34, reflecting a significant moment in its trading activity. Despite this day's positive movement, Stryker's performance over the past week has been less favorable, with a decline of 4.47%. Over the past month, the stock has decreased by 4.5%, and its year-to-date performance shows a slight decline of 0.54%. In contrast, the S&P 500 has shown resilience, with a year-to-date gain of 2.13%. Stryker's financial metrics reveal a market capitalization of USD 145.51 billion and a price-to-earnings ratio of 32.00. The company maintains a healthy debt-to-equity ratio of 0.53 and a return on equity of 17.83%. While the stock has faced challenges in the short term, it continues to demonstrate solid fundamentals, including a dividend yield of 0.89%.